ADSL and bacterial infectious disease with sepsis: Furthermore, the antibacterial effect of AMPs may also reduce the risk of bacteremia after peritoneal infection, as evidenced by the decrease in bacterial load in the blood observed in animals treated with mastoparan incorporated into chitosan nanostructures [31].